Butyrate Regulating Inflammatory Responses in Chronic Obstructive Pulmonary Disease via the Gut-Lung Axis
Qiang Liu, Qian Fu, Caiyuan Sun, Chanli Liu, Chan Xiong, Mei Chen · 2026
Read Butyrate Regulating Inflammatory Responses in Chronic Obstructive Pulmonary Disease via the Gut-Lung Axis by Qiang Liu, Qian Fu, Caiyuan Sun, Chanli Liu, Chan Xiong, Mei Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13525775.txt.
Description
Chronic obstructive pulmonary disease inflames the lungs for life, and inhalers ease symptoms without touching the wider inflammation behind it. Qiang Liu and five co-authors review a messenger from the gut in this 2026 paper: butyrate, a small acid made when gut microbes ferment fiber. The review gathers animal and early human evidence along the gut-lung axis.
The authors sort butyrate's actions into four routes. It firms the gut wall, calms an overactive immune cell type, and rebalances two arms of the T-cell system. It also breaks a harmful loop between blood vessel cells and macrophages. They are candid about limits. The benefits are best shown in the allergic-leaning form of the disease, which covers a minority of patients, and butyrate taken by mouth is largely consumed before it can act.
Catalog record
| CREATOR | Qiang Liu, Qian Fu, Caiyuan Sun, Chanli Liu, Chan Xiong, Mei Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |